When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Merck & Co has entered into a worldwide licensing deal with Opko Health’s ModeX Therapeutics unit for a vaccine candidate against Epstein-Barr virus (EBV) that could be worth up to $922.5 ...

The following is the transcript of an interview with former FDA commissioner Scott Gottlieb, Pfizer board member and ...

Celebrating independence can be important when living with multiple sclerosis, columnist Ben Hofmeister writes.

Researchers working on an incurable blood cancer can now use a new lab model that could make testing potential new treatments ...

Relapsing-remitting MS (RRMS) RRMS is the most common type of the disease. According to the National Multiple Sclerosis Society, about 85% of people with MS have RRMS at the time of diagnosis.

Many people with multiple sclerosis (MS) may wonder whether trying a certain diet — or eliminating a certain food group from their diet — can ward off MS symptoms, like fatigue or cognitive ...